Literature DB >> 19579631

Ante-situm liver resection in recurrent liver metastasis from colorectal cancer.

Zisun Kim1, Gui-Ae Jeong, Jun-Cheol Chung, Chong-Woo Chu, Eung-Jin Shin, Hyung-Chul Kim.   

Abstract

Surgical resection of liver metastases from colorectal cancer can offer long-term survival and cure in patients with metastatic colorectal cancer isolated to the liver. We present a case of a recurrent liver metastasis from rectal cancer, managed with ante-situm liver resection under total vascular exclusion and venovenous bypass with hypothermic perfusion. A 58-year-old man, who was diagnosed with liver metastasis from rectal cancer underwent a left lateral sectionectomy in January 2006. A recurrent lesion developed 1 year after the first hepatectomy. The tumor was 5 cm in size, locating at segments I, IV, and VIII. It was involved in the origin of middle hepatic vein and retro-hepatic vena cava. We performed ante-situm liver resection under total vascular exclusion and venovenous bypass with hypothermic perfusion. The patient remains well without recurrence for 12 months after the last operation. Ante-situm technique made it easy to approach and completely removes the recurrent lesion locating at hardly accessible site and having the incomplete removal risk by conventional liver resection. The authors also reconfirmed that repeat hepatectomy is valuable in recurrent colorectal liver metastases.

Entities:  

Mesh:

Year:  2009        PMID: 19579631

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Liver resection with concomitant inferior vena cava resection: experiences without veno-venous bypass.

Authors:  Stefan Stättner; Vincent Yip; Robert P Jones; Carmen Lacasia; Stephen W Fenwick; Graeme J Poston; Hassan Malik
Journal:  Surg Today       Date:  2013-06-26       Impact factor: 2.549

Review 2.  Liver resection under hypothermic total vascular exclusion.

Authors:  Sanjay Govil
Journal:  Indian J Gastroenterol       Date:  2013-03-10

Review 3.  Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.

Authors:  Taizo Hibi; Masahiro Shinoda; Osamu Itano; Yuko Kitagawa
Journal:  Organogenesis       Date:  2014-05-16       Impact factor: 2.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.